MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Anxiety in Parkinson’s disease is associated with changes in brain structural connectivity

    G. Carey, R. Viard, R. Lopes, G. Kuchcinski, L. Defebvre, A. Leentjens, K. Dujardin (Lille, France)

    Objective: The aim of this study was to identify White Matter (WM) changes by comparing Parkinson's disease (PD) patients with and without anxiety, using diffusion-tensor…
  • 2023 International Congress

    Genetic and psychiatric risk factors for impulse control disorders in de novo Parkinson’s disease

    M. Ruitenberg, E. Whooley, H. Macdonald, V. Koppelmans (Leiden, Netherlands)

    Objective: To assess the interplay of polygenic dopamine risk scores and psychiatric symptoms in the development of impulse control disorders (ICDs) in de novo patients…
  • 2023 International Congress

    Quantitative analysis of speech diadochokinetic rate in hereditary spastic paraplegia SPG3A

    V. Agrimaki, S. Siriopoulou, E. Zamba Papanicolaou, K. Christodoulou, K. Konstantopoulos (Kalamata, Greece)

    Objective: To analyze the dysarthria and speech diadochokinetic rate in a patient with hereditary spastic paraplegia (SPG3A). Background: Hereditary spastic paraplegias (HSP) are about 80…
  • 2023 International Congress

    Non-motor symptoms of Parkinson’s disease: an analysis of gender and age-related differences in a large online cohort

    D. Teixeira-Dos-Santos, G. Pereira, C. Rieder, A. Schumacher-Schuh (Porto Alegre, Brazil)

    Objective: This study analyzed non-motor symptoms in newly diagnosed Parkinson’s disease (PD) patients and controls in a large online cohort, comparing four groups based on…
  • 2023 International Congress

    Multicenter, randomized, placebo-controlled, double-blind, parallel-group proof-of-concept study of lixisenatide in patients with early Parkinson’s disease (PD): the LIXIPARK trial (NCT03439943)

    WG. Meissner, P. Remy, C. Giordana, D. Maltete, P. Damier, JL. Houeto, C. Geny, L. Hopes, F. Durif, G. Defer, C. Tranchant, JC. Corvol, N. Carriere, JP. Azulay, S. Drapier, P. Krystkowiak, C. Thalamas, A. Benard, O. Rascol, N. Ns-Park/fcrin (Bordeaux, France)

    Objective: To evaluate the “disease-modifying” effect of lixisenatide as adjunct to antiparkinsonian medications in patients with early PD. Background: Lixisenatide, a glucagon-like peptide 1 receptor…
  • 2023 International Congress

    Stability of basal ganglia beta band power distribution during continuous deep brain stimulation in Parkinson’s disease: analysis of sub-cohort from the ADAPT-PD trial

    L. Hammer, E. Yilmaz, S. Little, H. Zahed, M. Volz, S. Ravi, S. Wang, P. Starr, J. Ostrem (San Francisco, USA)

    Objective: To assess the stability of the daily distribution of peak subthalamic nucleus (STN) and globus pallidus internus (GPi) beta band power during continuous deep…
  • 2023 International Congress

    Evaluation of Cognitive Assessment Tools in Parkinson’s Disease

    L. Cao, Y. Huang (Beijing, China)

    Objective: To evaluate a variety of cognitive assessment scales in a longitudinal Parkinson’s disease (PD) cohort. Background: Cognitive impairment is one of the most common and…
  • 2023 International Congress

    Chronic pain and the polytrauma clinical triad are risk factors for prodromal PD

    L. Neilson, N. Balba, J. Elliott, G. Scott, M. Heinricher, M. Lim (Portland, USA)

    Objective: This study aimed to assess whether chronic pain is a risk factor for prodromal Parkinson disease and determine if pain severity and comorbidity with…
  • 2023 International Congress

    Sensitivity, consistency and test-retest reliability of home-based freezing of gait-provoking tests in people with Parkinson’s disease

    D. Zoetewei, P. Ginis, M. Gilat, T. Herman, M. Brozgol, P. Thumm, J. Hausdorff, A. Nieuwboer, N. D'Cruz (Leuven, Belgium)

    Objective: To evaluate the sensitivity, consistency and test-retest reliability of several freezing of gait (FOG)-provoking tests in the homes of people with Parkinson’s disease (PD)…
  • 2023 International Congress

    A Case of Post-malaria neurological syndrome presenting with tremor

    JS. Lee, JH. Ahn, JY. Youn, JH. Cho (Seoul, Republic of Korea)

    Objective: We report a case of post-malaria neurological syndrome (PMNS) presenting with tremor in a Korean patient. Background: PMNS is a rare neurological complication which…
  • « Previous Page
  • 1
  • …
  • 70
  • 71
  • 72
  • 73
  • 74
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Welcome to the MDS Abstracts Site
  • Advanced Search
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley